Reflecting growth across all its global regions, Nestle has reported a 7.5% increase in group sales to SFr44.1 billion (Eur36.7 billion) with net profit up 8.9% to SFr4.7 billion for the
Tag "Paul Bulcke"
Nestle has inaugurated two new production sites in South Africa as part of its continued commitment to accelerating the growth of its business in the region. They will enable the
In a strategic move to enhance its position in global infant nutrition, Nestle has agreed to acquire Pfizer Nutrition for $11.85 billion (Eur9.01 billion). Nestle estimates Pfizer Nutrition’s 2012 sales
Reflecting growth in both emerging markets and developed markets, Nestle increased net profit by 8.1% on a continuing basis to SFr9.5 billion (Eur7.8 billion) for 2011 on sales of SFr83.6
Private sector companies have an important role to play in addressing the global food crisis, according to Nestlé chief executive Paul Bulcke. In a speech at the ‘Feeding the World’
Nestle has completed a SFr240 million (Eur195 million) expansion of its soluble coffee factory in Timashevsk, Russia. Located in the Krasnodar region, the site is Nestle’s largest soluble coffee factory
Nestle will invest more than SFr98 million (Eur83 million) in Thailand to increase manufacturing of its products including coffee and ice cream. The two year investment will support the expansion
Nestle has produced a solid financial performance in the first half and is predicting organic sales growth at the top end of the 5% to 6% range and a margin
Reporting growth across all regions and categories, Nestle achieved a 6.2% organic growth in 2010 group sales to SFr109.7b (Eur84.9b) with real internal growth of 4.6% and tripled net profits
Nestle has reaffirmed its commitment to the Middle East by opening a new $136m manufacturing facility in Dubai to serve the Swiss food giant’s markets across the region. The 515,000
Nestle remains on track to deliver on its earlier forecast of full-year organic growth of around 5% combined with an EBIT margin increase in constant currencies in its food and
Nestle is creating Nestle Health Science and the Nestle Institute of Health Sciences to pioneer a new industry between food and pharma. These two separate organisations will allow Nestle to
Nestle has completed the sale of its remaining 52% stake in Alcon, the global eye care business, to Novartis for $28.3b. Nestle acquired Alcon in 1977 for $280m. Over the
Benefiting from deeper penetration in emerging markets of the world, the continued success of its premium products in both developing and developed markets and extra marketing investment, Nestle has increased
Nestle has completed the acquisition of Vitaflo, a Liverpool-based global provider of clinical nutritional products which has enjoyed double-digit growth in the order of 30% over the last three years.
Paul Bulcke, chief executive of Nestle, supports the move to drive the European Union to toughen greenhouse gas emissions reduction targets. In a signed letter together with 26 business leaders
In line with its strategy of expanding in emerging regions of the world, Nestle will invest SFr150m (Eur110m) in the Equatorial African Region (EAR) over the next three years by
The Magazine
Advertisements
